Title:  Assistant Professor

Department:  Department of Pharmacy Practice

School/Center:  School of Pharmacy

Office Location:  245 Mugar Hall

Phone:  617-373-7115

Fax:  617-373-7655

Email:  c.teter@neu.edu

Education:  Post-doctoral research fellow, National Institute on Drug Abuse & University of Michigan

Pharm.D., University of Michigan

Medical Technology, Michigan State University

Certification:  Board Certified Psychiatric Pharmacist (BCPP)

Specializations:  Psychiatry & Substance Use Disorders

Research:  Clinical research studies aimed at understanding and improving medication adherence among patients with co-occurring psychiatric and substance use disorders.

Pharmacoepidemiologic methods used to identify the prevalence, patterns and motives for prescription drug abuse and diversion among various populations.

Pharmacokinetic analyses and modeling of drugs of abuse and medications used to treat substance use disorders.

Research site: McLean Hospital, Alcohol & Drug Abuse Treatment Program; Phone: 617-855-2155; e-mail: cteter@mclean.harvard.edu

Courses:   Research Directed Study (PMD U964), Alcohol & Drug Abuse Treatment Program, McLean Hospital (Belmont, MA).  This directed study involves patient interviewing, medical records review, data entry and verification, data analysis and occasionally poster and manuscript preparation.  Hours: 2-8 hours/week, usually between 11:00 a.m. to 4:00 p.m.

Selected Publications: 

1.Teter CJ, Early JJ, Gibbs CM. Treatment of affective disorder and obesity with topiramate. Annals of Pharmacotherapy 2000; 34:1262-1265.

2.Teter CJ, Guthrie SK.  A comprehensive review of MDMA (“Ecstasy”) and GHB: two common club drugs.  Pharmacotherapy 2001; 21:1486-1513.

3.Teter CJ, McCabe SE, Boyd CJ, Guthrie SK. Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors. Pharmacotherapy 2003; 23:609-617.

4.McCabe SE, Knight JR, Teter CJ, Wechsler H.  Nonmedical use of prescription stimulants among U.S. college students: prevalence and correlates from a national survey.  Addiction 2005; 100:96–106.

5.McCabe SE, Teter CJ, Boyd CJ. Illicit use of prescription pain medication among college students. Drug and Alcohol Dependence 2005; 77:37–47.

6.Teter CJ, McCabe SE, Cranford JA, Boyd CJ, Guthrie SK. Prevalence and motivations for the illicit use of prescription stimulants in an undergraduate student sample. Journal of American College Health 2005; 53:253-262.

7.Teter CJ, McCabe SE, LaGrange KB, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 2006; 26:1501-1510.

8.Kaloyanides KB, McCabe SE, Cranford JA, Teter CJ. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationships with the age of initiation of prescribed stimulants. Pharmacotherapy 2007; 27:666–674.

9.McCabe SE, Teter CJ. Drug use related problems among nonmedical users of prescription stimulants: A web-based survey of college students from a Midwestern university. Drug Alcohol Dependence 2007; 91:69–76.

10.Wasan AD, Michna E, Janfaza D, Greenfield S, Teter CJ, Jamison RN. Interpreting Urine Drug Tests: Prevalence of Morphine Metabolism to Hydromorphone in Chronic Pain Patients Treated with Morphine. Pain Medicine 2007 (Published article online: 28-Aug-2007).

11.Pomykacz B, Mao M, Weiss RD, Teter CJ. A Review of Brief Medication-Adherence Instruments Used in Patients with Schizophrenia and Bipolar Disorder. Harvard Review of Psychiatry 2007; 15: 259-263.